Company to Enter the $94 Billion European Clinical Device Market BOSTON, Oct. 14 (HSMN NewsFeed) — Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company has taken the initial steps to obtain the CE Mark for its Food and Dr…
Devices, Regulatory
Solos Endoscopy, MammoView
Posts on ‘October 13th, 2009’
Solos Endoscopy, Inc.’s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
Seattle Genetics Names Head of Commercial and Announces Management Promotion
BOTHELL, Wash.–(HSMN NewsFeed)–Seattle Genetics, Inc. (Nasdaq: SGEN ) today announced the appointment of Bruce J. Seeley as Executive Vice President, Commercial. Mr. Seeley brings more than 18 years of experience in oncology drug marketing and revenue to t…
Biopharmaceuticals, Personnel
Seattle Genetics
CalciMedica Appoints Evelyn Graham to its Board of Directors
LA JOLLA, Calif., Oct. 13 (HSMN NewsFeed) — CalciMedica, a biotechnology company focused on developing innovative therapeutics for the treatment of autoimmune and inflammatory diseases, announced today that Evelyn Graham, the former Chief Executive Offi…
Biopharmaceuticals, Personnel
CalciMedica
CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator
New ventilator technology provides versatility, portability and may help to improve patient care by reducing the need for multiple or transport ventilators SAN DIEGO, Oct. 13 (HSMN NewsFeed) — CareFusion Corporation (NYSE: CFN ), a new clinical and m…
Devices
CareFusion, EnVe , ventilator
Amarin Announces Changes to Its Board and Management Team
DUBLIN, Oct., 13–(HSMN NewsFeed)–Amarin Corporation plc (NASDAQ:AMRN ) today announced changes to its board and management team, in conjunction with its separately announced $70 million private placement. Following the closing of the financing, Mr. Th…
Biopharmaceuticals, Personnel
Amarin Corp

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.